General Information

MaintermDIDODECYL-1,4-DIHYDRO-2,6-DIMETHYL-3,5-PYRIDINEDICARBOXYLAATE
CAS Reg.No.(or other ID)36265-41-5
Regnum 178.2010

From www.fda.gov

Computed Descriptors

Download SDF
2D Structure
CID118933
IUPAC Namedidodecyl 2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate
InChIInChI=1S/C33H59NO4/c1-5-7-9-11-13-15-17-19-21-23-25-37-32(35)30-27-31(29(4)34-28(30)3)33(36)38-26-24-22-20-18-16-14-12-10-8-6-2/h34H,5-27H2,1-4H3
InChI KeyVEUDMQNHACTHAL-UHFFFAOYSA-N
Canonical SMILESCCCCCCCCCCCCOC(=O)C1=C(NC(=C(C1)C(=O)OCCCCCCCCCCCC)C)C
Molecular FormulaC33H59NO4

From Pubchem


Computed Properties

Property Name Property Value
Molecular Weight533.838
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count26
Complexity652.0
CACTVS Substructure Key Fingerprint A A A D c f B + O A A A A A A A A A A A A A A A A A A A A A A A A A A g A A A A A A A A A A A A A A A A H g A Q A A A A D A i h g A I C C A L A B A C I A g T Q S A A A A A A g A A A A C A E A A E g A B B I A I A A C E A A E k A C I I U O I 5 q g A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A A = =
Topological Polar Surface Area64.6
Monoisotopic Mass533.444
Exact Mass533.444
XLogP3None
XLogP3-AA12.3
Compound Is CanonicalizedTrue
Formal Charge0
Heavy Atom Count38
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Isotope Atom Count0
Covalently-Bonded Unit Count1

From Pubchem


ADMET Predicted Profile --- Classification

Model Result Probability
Absorption
Blood-Brain BarrierBBB+0.5284
Human Intestinal AbsorptionHIA+0.9605
Caco-2 PermeabilityCaco2+0.5412
P-glycoprotein SubstrateSubstrate0.6020
P-glycoprotein InhibitorInhibitor0.7380
Non-inhibitor0.9093
Renal Organic Cation TransporterNon-inhibitor0.8236
Distribution
Subcellular localizationMitochondria0.8051
Metabolism
CYP450 2C9 SubstrateNon-substrate0.9062
CYP450 2D6 SubstrateNon-substrate0.8481
CYP450 3A4 SubstrateSubstrate0.5550
CYP450 1A2 InhibitorNon-inhibitor0.5647
CYP450 2C9 InhibitorNon-inhibitor0.5546
CYP450 2D6 InhibitorNon-inhibitor0.8304
CYP450 2C19 InhibitorNon-inhibitor0.5055
CYP450 3A4 InhibitorInhibitor0.5075
CYP Inhibitory PromiscuityHigh CYP Inhibitory Promiscuity0.5431
Excretion
Toxicity
Human Ether-a-go-go-Related Gene InhibitionWeak inhibitor0.7526
Non-inhibitor0.9103
AMES ToxicityNon AMES toxic0.8114
CarcinogensNon-carcinogens0.9270
Fish ToxicityHigh FHMT0.9574
Tetrahymena Pyriformis ToxicityHigh TPT0.9994
Honey Bee ToxicityHigh HBT0.5551
BiodegradationReady biodegradable0.5738
Acute Oral ToxicityIII0.6057
Carcinogenicity (Three-class)Non-required0.5868

From admetSAR


ADMET Predicted Profile --- Regression

Model Value Unit
Absorption
Aqueous solubility-3.5685LogS
Caco-2 Permeability0.9666LogPapp, cm/s
Distribution
Metabolism
Excretion
Toxicity
Rat Acute Toxicity1.7330LD50, mol/kg
Fish Toxicity0.7529pLC50, mg/L
Tetrahymena Pyriformis Toxicity0.8030pIGC50, ug/L

From admetSAR


Taxonomic Classification

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
ClassPyridines and derivatives
SubclassHydropyridines
Intermediate Tree NodesDihydropyridines
Direct ParentDihydropyridinecarboxylic acids and derivatives
Alternative Parents
Molecular FrameworkAliphatic heteromonocyclic compounds
SubstituentsDihydropyridinecarboxylic acid derivative - Dicarboxylic acid or derivatives - Enoate ester - Alpha,beta-unsaturated carboxylic ester - Vinylogous amide - Amino acid or derivatives - Carboxylic acid ester - Carboxylic acid derivative - Secondary aliphatic amine - Enamine - Secondary amine - Azacycle - Organic nitrogen compound - Organic oxide - Organopnictogen compound - Amine - Organic oxygen compound - Organonitrogen compound - Organooxygen compound - Carbonyl group - Hydrocarbon derivative - Aliphatic heteromonocyclic compound
DescriptionThis compound belongs to the class of organic compounds known as dihydropyridinecarboxylic acids and derivatives. These are compounds containing a dihydropyridine moiety bearing a carboxylic acid group.

From ClassyFire